ML239
SIGMA/SML0442 - ≥98% (HPLC)
Synonym: (2,4,6-
CAS Number: 1378872-36-6
Empirical Formula (Hill Notation): C13H10Cl3N3O2
Molecular Weight: 346.60
MDL Number: MFCD23098913
Linear Formula: C13H10Cl3N3O2
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C13H10Cl3N3O2/c14-8-4- |
InChI key | NVEDPFICKAIHKD-NGYBGAFCSA |
Quality Level | 100 ![]() |
SMILES string | Clc1cc(Cl)c(OCC(=O)NN=C |
solubility | DMSO: 15 mg/mL (clear solution) |
storage temp. | 2-8°C |
Application: | ML239 has been used as a proble in cellular lipid profiling. |
Biochem/physiol Actions: | ML239 decreases the saturated and monounsaturated lysophosphatidylethanolam |
Biochem/physiol Actions: | ML239 is an inhibitor of breast cancer stem cells found from a screen using stem cell-like human mammary epithelial cells (HMLE). ML239 inhibited cancer stem cells with an IC50 of 1.16 μM with 24-fold selectivity against the control cell line. |
Packaging: | 5, 25 mg in glass bottle |
Symbol | ![]() ![]() |
Signal word | Warning |
Hazard statements | H302 + H312 + H332 - H315 - H319 - H335 - H400 |
Precautionary statements | P273 - P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Statements | 20/21/22-36/37/38 |
Safety Statements | 26 |
RIDADR | UN 3077 9 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |